🚀 Major breakthrough in quantum algorithms: Qubit Pharmaceuticals and Sorbonne Université drastically reduce the number of qubits needed to simulate molecules - from over 250 to just 20! We're thrilled to announce that this achievement, powered by our Hyperion-1 emulator, has secured €8 million in funding from the France 2030 plan within the i-Démo programme, powered by Bpifrance and Secretary general for investment. 🌟 We'd like to thank all the partners involved - especially Sorbonne Université, Scaleway & GENCI - this milestone brings us closer to the practical application of hybrid HPC-quantum computing in drug discovery, reinforcing our goal to pioneer molecular modeling-based drug discovery. Find out all the details and statements in the press release below! #QuantumforPharma #QuantumComputing #DrugDiscovery #idemo
I have an AI "hallucination" when I read that ONLY €8Million are being offered by major contributors, outrageous partners and the french government to reinforce a deep tech company specialising in the discovery of new drug candidates through molecular simulation using NEW Quantum computing technology. 👎 Becoming a pharma leader in Europe and France in the coming years will need higher investments. The multidisciplinary team, led by CEO Robert Marino, and the founders are based in France at the Paris Santé Cochin incubator and in the USA in Boston. For more information, or to join the ambitious team, visit www.qubit-pharmaceuticals.com
Congratulations
Where paper?
Is the methodology published? Can you share the link?
Scaleway is delighted to be part of this great adventure! cc Sébastien Luttringer Amaury Simon - JM
Curious to see the gain in prediction accuracy you might get (still in a reasonable computing-time) compared with traditional Forcefield-based systems. Interesting times ahead !
Big congrats to Robert Marino and the QuBit team! Pharma companies are very much expecting quantum computing to enhance our drug discovery capabilities!
Congrats !!
Amazing!
Very proud at GENCI to support since many years the development of Qubit Pharmaceuticals with our #HPC, #AI and now #QC computing facilites. Look forward for the next joint adventure on the new partition of Jean Zay (at IDRIS CNRS - Centre national de la recherche scientifique) and on our Pasqal quantum computer at TGCC (CEA) 🚀